*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Velpatasvir is a potent direct-acting antiviral agent (DAA) used in the treatment of Hepatitis C. It functions as a pan-genotypic NS5A inhibitor, typically synthesized via complex organic catalysis. Key chemical parameters include molecular formula <strong>C28H21ClF3N4O</strong> and CAS No. <strong>1576097-07-8</strong>.</p>
<h3>Application</h3>
<ul>
<li>Hepatology: First-line therapy for chronic HCV infection across all major genotypes.</li>
<li>Pharmaceutical Manufacturing: Active Pharmaceutical Ingredient (API) for fixed-dose combination tablets.</li>
<li>Global Health Programs: Integrated into WHO-prequalified regimens for mass treatment initiatives.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly contraindicated with certain anti-seizure medications due to metabolic interactions. Storage requires controlled room temperature (15-30°C) in moisture-proof containers to maintain chemical stability and potency.</p>